BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
3301
Dynex Capital
DX
$3.23B
| $54.9K | ﹤0.01% |
3,714
-1,026
| -22% | -$16K |
|
3302
Vishay Precision Group
VPG
$908M
| $54.8K | ﹤0.01% |
1,675
+315
| +23% | +$11.2K |
|
3303
FRP Holdings
FRPH
$425M
| $54.8K | ﹤0.01% |
2,284
+290
| +15% | +$7.23K |
|
3304
MarineMax
HZO
$1.15B
| $54.8K | ﹤0.01% |
3,542
+1,083
| +44% | +$16.6K |
|
3305
Carter Bankshares
CARE
$757M
| $54K | ﹤0.01% |
2,861
+1,769
| +162% | +$34.2K |
|
3306
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $53.8K | ﹤0.01% |
1,600
| – | – |
|
|
AHT
3307
Ashford Hospitality Trust
AHT
$20.2M
| $53.7K | ﹤0.01% |
16
-4
| -20% | -$11.2K |
|
3308
Mitek Systems
MITK
$853M
| $53.7K | ﹤0.01% |
5,568
+1,436
| +35% | +$14.3K |
|
3309
Arvinas
ARVN
$589M
| $53.6K | ﹤0.01% |
2,488
+1,535
| +161% | +$37.7K |
|
|
ORC
3310
Orchid Island Capital
ORC
$1.32B
| $53.6K | ﹤0.01% |
1,865
+294
| +19% | +$8.92K |
|
3311
Energy Recovery
ERII
$399M
| $53.6K | ﹤0.01% |
5,780
+1,478
| +34% | +$14.9K |
|
3312
Utah Medical Products
UTMD
$230M
| $53.5K | ﹤0.01% |
558
+148
| +36% | +$13.8K |
|
3313
Capital City Bank Group
CCBG
$898M
| $53.4K | ﹤0.01% |
1,944
+23
| +1% | +$581 |
|
3314
UNIFI
UFI
$120M
| $53.4K | ﹤0.01% |
2,434
-46
| -2% | -$906 |
|
|
PRNB
3315
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $53.3K | ﹤0.01% |
1,887
+1,149
| +156% | +$42.1K |
|
3316
CRA International
CRAI
$1.07B
| $53.3K | ﹤0.01% |
1,269
+59
| +5% | +$2.4K |
|
|
BGG
3317
DELISTED
Briggs & Stratton Corp.
BGG
| $53.2K | ﹤0.01% |
8,779
-1,644
| -16% | -$12.2K |
|
|
EGIO
3318
DELISTED
Edgio, Inc. Common Stock
EGIO
| $53K | ﹤0.01% |
438
+31
| +8% | +$3.27K |
|
3319
Mistras Group
MG
$584M
| $52.9K | ﹤0.01% |
3,228
| – | – |
|
|
SILK
3320
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $52.9K | ﹤0.01% |
1,626
+1,454
| +845% | +$57.9K |
|
3321
Magnite
MGNI
$3.53B
| $52.9K | ﹤0.01% |
6,072
+3,084
| +103% | +$27K |
|
|
DF
3322
DELISTED
Dean Foods Company
DF
| $52.8K | ﹤0.01% |
45,479
-11,227
| -20% | -$13.3K |
|
|
PCSB
3323
DELISTED
PCSB Financial Corporation
PCSB
| $52.6K | ﹤0.01% |
2,633
+98
| +4% | +$1.94K |
|
3324
CALL
FMC
FMC
$1.27B
| $52.6K | ﹤0.01% |
6
| – | – |
|
|
3325
PUT
FMC
FMC
$1.27B
| $52.6K | ﹤0.01% |
6
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.